Can-Fite BioPharma American Depositary Shares
CANF
3 hedge funds and large institutions have $1.59M invested in Can-Fite BioPharma American Depositary Shares in 2017 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 0 reducing their positions, and 5 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
23% less capital invested
Capital invested by funds: $2.07M → $1.59M (-$476K)
50% less funds holding
Funds holding: 6 → 3 (-3)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$60.7K |
| 2 |
PVH
Psagot Value Holdings
Tel Aviv,
Israel
|
+$6.07K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Menta Capital
San Francisco,
California
|
-$100K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$34K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$29K |
| 4 |
Morgan Stanley
New York
|
-$6.07K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TAM
1
Taylor Asset Management
Toronto,
Ontario, Canada
| $1.53M | – | – | – |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $57K | +$60.7K | +10 | New |
|
|
PVH
3
Psagot Value Holdings
Tel Aviv,
Israel
| $6K | +$6.07K | +1 | New |
|
|
4
Morgan Stanley
New York
| $1K | -$6.07K | -1 | Closed |
|
5
Simplex Trading
Chicago,
Illinois
| $1K | – | – | – |
|
|
MC
6
Menta Capital
San Francisco,
California
| – | -$100K | -14 | Closed |
|
|
7
Citadel Advisors
Miami,
Florida
| – | -$34K | -5 | Closed |
|
|
VKH
8
Virtu KCG Holdings
New York
| – | -$29K | -4 | Closed |
|
|
9
UBS Group
Zurich,
Switzerland
| – | -$6K | -1 | Closed |
|
CANF Hedge Fund Activity: Q1 2017 in Review
3 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q1 2017, worth a combined $1.59M — down 23% from $2.07M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of CANF and 2 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Sabby Management, opening a new position worth an estimated $60.7K. The largest seller was Menta Capital, exiting entirely with an estimated $100K sold.
- 3 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q1 2017, down from 6 in Q4 2016.
- Funds reported $1.59M of Can-Fite BioPharma American Depositary Shares stock for Q1 2017, down 23% quarter-over-quarter.
- 2 funds opened new Can-Fite BioPharma American Depositary Shares positions in Q1 2017 and 5 closed out, a net change of -3 holders.
- The largest Can-Fite BioPharma American Depositary Shares buyer in Q1 2017 was Sabby Management, an estimated $60.7K added.
- The largest Can-Fite BioPharma American Depositary Shares seller in Q1 2017 was Menta Capital, an estimated $100K sold.
Based on aggregated 13F filings for Q1 2017.